#news #biotech Erytech doubles down on solid tumor trials for red cell drug therapy

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Erytech doubles down on solid tumor trials for red cell drug therapy .After disappointing data in leukemia, France’s Erytech is refocusing its red blood cell-encapsulated drug therapy to solid tumors—and will target triple-negative breast cancer in its next trial.

from FierceBiotech: Biotech http://ift.tt/2EDsaNv